home / stock / hem:cc / hem:cc quote
Last: | $0.35 |
---|---|
Change Percent: | 6.06% |
Open: | $0.335 |
Close: | $0.35 |
High: | $0.35 |
Low: | $0.335 |
Volume: | 165,164 |
Last Trade Date Time: | 05/06/2022 04:55:48 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.35 | $0.335 | $0.35 | $0.35 | $0.335 | 165,164 | 05-06-2022 |
$0.33 | $0.32 | $0.33 | $0.365 | $0.32 | 434,922 | 05-05-2022 |
$0.31 | $0.28 | $0.31 | $0.32 | $0.28 | 293,326 | 05-04-2022 |
$0.29 | $0.3 | $0.29 | $0.3 | $0.29 | 92,723 | 05-03-2022 |
$0.29 | $0.3 | $0.29 | $0.305 | $0.29 | 388,393 | 05-02-2022 |
$0.295 | $0.315 | $0.295 | $0.32 | $0.295 | 239,085 | 04-29-2022 |
$0.315 | $0.325 | $0.315 | $0.325 | $0.3 | 294,213 | 04-28-2022 |
$0.32 | $0.31 | $0.32 | $0.33 | $0.305 | 346,226 | 04-27-2022 |
$0.36 | $0.3 | $0.36 | $0.365 | $0.3 | 216,835 | 04-26-2022 |
$0.3 | $0.335 | $0.3 | $0.335 | $0.3 | 70,081 | 04-25-2022 |
$0.34 | $0.34 | $0.34 | $0.345 | $0.33 | 27,909 | 04-22-2022 |
$0.32 | $0.35 | $0.32 | $0.35 | $0.32 | 58,652 | 04-21-2022 |
$0.325 | $0.35 | $0.325 | $0.38 | $0.325 | 528,691 | 04-20-2022 |
$0.345 | $0.315 | $0.345 | $0.39 | $0.265 | 2,089,656 | 04-19-2022 |
$0.305 | $0.29 | $0.305 | $0.33 | $0.285 | 835,155 | 04-18-2022 |
$0.28 | $0.23 | $0.28 | $0.29 | $0.23 | 516,466 | 04-15-2022 |
$0.28 | $0.23 | $0.28 | $0.29 | $0.23 | 516,466 | 04-14-2022 |
$0.22 | $0.19 | $0.22 | $0.225 | $0.18 | 355,824 | 04-13-2022 |
$0.18 | $0.19 | $0.18 | $0.19 | $0.18 | 222,786 | 04-12-2022 |
$0.19 | $0.19 | $0.19 | $0.19 | $0.185 | 73,653 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Hemostemix Inc. Company Name:
HEM:CC Stock Symbol:
TSXVC Market:
A look at the top 10 most actives in Canada Royal Bank of Canada (RY) fell 0.9% to $135.13 on volume of 3,757,883 shares Rogers Communications Inc. Class B Non-voting Shares (RCI.B) fell 0.5% to $53.81 on volume of 3,042,339 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 7...
Calgary, Alberta--(Newsfile Corp. - March 7, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. ("OHAM"), an Exempt Market Dealer to provide capital markets advice rel...
Calgary, Alberta--(Newsfile Corp. - February 6, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company's Phase II randomized clinical trial results ...